Hospital
Chca West Houston L P
Chca West Houston L P was paid $11.10M by Medicaid between Jul 2020 and Dec 2024, across 61 billing codes. Its largest line is 99284, emergency room visit (serious) — 52% of everything it billed.
33Billing provider infoCHCA WEST HOUSTON L P
HOUSTON, TX 77082
HOUSTON, TX 77082
33aNPI1275580938assigned 05/28/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.10M
24GClaims137,101
24DCodes billed61
24AFirst – last monthJul 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#16 of 109
Median peer was paid$1.15M
This provider vs. median9.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 3,204 | $494K | |
| 2021 | 28,046 | $3.00M | |
| 2022 | 43,207 | $3.09M | |
| 2023 | 40,723 | $3.23M | |
| 2024incomplete | 21,921 | $1.28M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 52% | 10,967 | 10,298 | $5.76M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 35% | 27,123 | 26,214 | $3.93M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.1% | 11,052 | 10,737 | $230K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 10,247 | 9,045 | $188K |
| 71045 | Radiologic examination, chest; single view | 1.1% | 6,238 | 6,026 | $119K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,485 | 2,257 | $108K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 1,039 | 937 | $80K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,841 | 1,716 | $67K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 6,042 | 5,920 | $64K |
| 85027 | <1% | 13,107 | 12,039 | $52K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,407 | 5,001 | $48K |
| 87634 | <1% | 974 | 962 | $47K |
49 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 347 | $46K |
| 80053 | Comprehensive metabolic panel | <1% | 4,267 | $43K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 142 | $34K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 786 | $33K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 595 | $32K |
| 76801 | <1% | 315 | $30K | |
| 87081 | <1% | 4,521 | $26K | |
| 93976 | <1% | 255 | $24K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 877 | $23K |
| 81001 | <1% | 6,801 | $21K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 702 | $15K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,510 | $10K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 68 | $7K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 79 | $6K |
| 84702 | <1% | 582 | $5K | |
| 83690 | <1% | 1,680 | $5K | |
| 80076 | <1% | 813 | $4K | |
| 81025 | <1% | 675 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 438 | $4K |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | <1% | 12 | $4K |
| 84484 | <1% | 1,552 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 173 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,818 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,079 | $2K |
| 81003 | <1% | 917 | $2K | |
| 84703 | <1% | 636 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 79 | $2K |
| 86900 | <1% | 614 | $1K | |
| 83880 | <1% | 204 | $1K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 38 | $1K |
| 86901 | <1% | 614 | $870.99 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 31 | $784.52 |
| 82248 | <1% | 646 | $758.71 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 88 | $636.80 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 38 | $547.84 |
| 84030 | <1% | 74 | $527.02 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 13 | $427.52 |
| 85610 | <1% | 305 | $371.35 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 762 | $361.22 |
| 74018 | <1% | 12 | $273.07 | |
| 83605 | <1% | 64 | $165.31 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 118 | $102.17 |
| 82077 | <1% | 38 | $99.50 | |
| 85730 | <1% | 73 | $60.60 | |
| 87040 | <1% | 13 | $34.68 | |
| 83735 | <1% | 17 | $33.29 | |
| A9270 | Non-covered item or service | 0% | 2,006 | $0.00 |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 77 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUSSO, KENNETH (CFO)